An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)
Status:
Completed
Trial end date:
2000-12-01
Target enrollment:
Participant gender:
Summary
The objectives of this study were to study the pharmacokinetics, pharmacodynamics and safety
of Org 36286 after a single subcutaneous administration in healthy females.